Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
US pharma major Eli Lilly has launched in India its eagerly awaited diabetes and obesity drug Mounjaro (tripeptide). The launch of this breakthrough medicine is an important step toward dealing ...
The much-awaited weightloss and diabetes drug, Mounjaro from US-based Eli Lilly and Company will be available at local chemists in a few weeks, at an India-specific price. Globally Mounjaro ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback